Want to reach an audience of more than 30,000 readers each month? The French Tech Journal is the leading English-language media platform covering France's dynamic tech ecosystem. With 31,000 + engaged readers across key global markets and consistently high engagement rates, our sponsorships provide unparalleled access to decision-makers in French tech.
🔥🔥🔥🔥
📇 Company: Solveo Energie
🔍 Description: Renewable energy, specifically wind energy
💻 Website: http://solveo-energie.com
📍 HQ City: Fenouillet
🧗 Round: Late VC
💰 Amount Raised: €98M
🏦 Investors: Mirova
👨💼👩💼 Founders: Jean-Marc Mateos
🗞️ News: ESG Today
📇 Company: Quobly
🔍 Description: Quantum computing startup developing scalable silicon-based 100-qubit chip technology.
💻 Website: https://quobly.io
📍 HQ City: Grenoble
🧗 Round: Series A
💰 Amount Raised: €21m
🏦 Investors: Quantonation, Bpifrance, Supernova Invest, 50 Partners, CEA Investissement, Fonds Innovation Défense
👨💼👩💼 Founders: François Perruchot, Maud Vinet, and Tristan Meunier
🗞️ News: Data Center Dynamics, Quobly
📇 Company: Amplitude Studios
🔍 Description: PC games and development
💻 Website: https://www.amplitude-studios.com
📍 HQ City: Paris
🧗 Round: Series A
💰 Amount Raised: €12M
🏦 Investors: Bpifrance, Griffin Gaming Partners
👨💼👩💼 Founders: Romain de Waubert de Genlis
🗞️ News: GamesBeat
📇 Company: Hemerion Therapeutics
🔍 Description: Innovative technology for treating glioblastoma and advancing cancer therapies
💻 Website: https://www.hemerion.com/
📍 HQ City: Villeneuve-d'Ascq
🧗 Round: Series A
💰 Amount Raised: €6.5M
🏦 Investors: Capital Cell, Finovam, Nord France Amorçage, CAPTECH Santé Nutrition
👨💼👩💼 Founders: Serge Mordon
🗞️ News: PR
📇 Company: Kyron.bio
🔍 Description: Bioproduction platform enhancing therapeutic drug yield and stability for life-saving treatments
💻 Website: https://www.kyron.bio/
📍 HQ City: Paris
🧗 Round: Seed
💰 Amount Raised: €5.5M
🏦 Investors: Verve Ventures, Entrepreneur First, HCVC, Saras Capital
👨💼👩💼 Founders: Emilia McLaughlin, Vaibhav Longani
🗞️ News: FrenchWeb
📇 Company: Dastra
🔍 Description: SaaS software enabling organizations to comply with privacy laws such as GDPR
💻 Website: http://dastra.eu
📍 HQ City: Saint-Mandé
🧗 Round: Seed
💰 Amount Raised: €4.3M
🏦 Investors: C4 Ventures, Adnexus
👨💼👩💼 Founders: Paul-Emmanuel Bidault, Romain Bidault
🗞️ News: Planet Fintech
📇 Company: Ecomer
🔍 Description: Developer of maritime safety equipment and software solutions aimed at decarbonizing professional shipping fleets.
💻 Website: https://ecomer-data.fr/
📍 HQ City: Nantes
🧗 Round: Seed
💰 Amount Raised: €2m
🏦 Investors: Bpifrance (Fonds de Décarbonation de la Filière Maritime), Mer Invest
👨💼👩💼 Founders: Geoffroy Lacoin, Jean Brossollet
🗞️ News: LinkedIn
📇 Company: Novem
🔍 Description: Biotech startup using Grenoble walnuts for use in sustainable cosmetics.
💻 Website: https://www.novemlab.co/en
📍 HQ City: Grenoble
🧗 Round: Seed
💰 Amount Raised: €638k
🏦 Investors: Grenoble Angels, Business Angels
👨💼👩💼 Founders: Maegan Rocca
🗞️ News: Lyon Entreprises
📇 Company: Danim
🔍 Description: Digital agency using AI to provide communication solutions for real estate professionals.
💻 Website: https://www.danim.com/
📍 HQ City: Lyon
🧗 Round: Seed
💰 Amount Raised: €2m
🏦 Investors: Business Angels
👨💼👩💼 Founders: Danyl Hassim
🗞️ News: ImmoMatin
Other Funding News
📇 Company: Ankar
🔍 Description: Helping IP and R&D teams streamline patent search, filing, analysis, and infringement detection across the entire IP lifecycle.
💻 Website: https://ankar.ai/
📍 HQ City: London
🧗 Round: Seed
💰 Amount Raised: 3M pounds
🏦 Investors: Index Ventures, Olivier Pomel, Daphni, Julien Chaumond, Motier Ventures, Puzzle Ventures, Booom
👨💼👩💼 Founders: Wiem Gharbi, Tamar Gomez (French co-founders)
🗞️ News: Sifted, Tech.eu
📇 Company: TreeFrog Therapeutics
🔍 Description: Stem cell company enabling broader patient access to cell therapies
💻 Website: https://treefrog.fr
📍 HQ City: Pessac
🧗 Round: Quasi-Equity
💰 Amount Raised: €30M
🏦 Investors: European Investment Bank
👨💼👩💼 Founders: Kévin Alessandri, Jean-Luc Treillou, Erwan Bezard
🗞️ News: This financing is part of a new model set up by the EIB for biotechs, in this case to support ongoing trials. Unlike conventional debt, quasi-equity allows for increased financial flexibility without immediate dilution of capital.
